Suppr超能文献

Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.

作者信息

Gorr Matthew W, Wold Loren E

机构信息

Dorothy M. Davis Heart and Lung Research Institute, College of Medicine and College of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, 43210, USA.

Dorothy M. Davis Heart and Lung Research Institute, College of Medicine and College of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, 43210, USA.

出版信息

Curr Opin Pharmacol. 2020 Oct;54:vii-ix. doi: 10.1016/j.coph.2020.12.003.

Abstract
摘要

相似文献

3
Diabetes and hypertension: a comprehensive report on management and the prevention of cardiovascular and renal complications.
J Clin Hypertens (Greenwich). 2011 Apr;13(4):221-3. doi: 10.1111/j.1751-7176.2011.00453.x.
5
Results from Cardiovascular Outcome Trials in Diabetes.
Endocrinol Nutr. 2016 Aug-Sep;63(7):317-9. doi: 10.1016/j.endonu.2016.04.001. Epub 2016 Jun 17.
6
SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection.
Lancet Diabetes Endocrinol. 2018 Jun;6(6):435-437. doi: 10.1016/S2213-8587(17)30314-5. Epub 2017 Oct 10.
7
Preventing Cardiovascular Disease in Patients With Diabetes: New Evidence Informs Changes in Standards of Care.
J Cardiovasc Nurs. 2016 May-Jun;31(3):198-200. doi: 10.1097/JCN.0000000000000333.
8
The reno-cardiovascular connection in the patient with Diabetes mellitus: What's new?
Endocrinol Diabetes Nutr. 2017 May;64(5):237-240. doi: 10.1016/j.endinu.2017.03.006. Epub 2017 Apr 26.

本文引用的文献

1
Metformin: still the sweet spot for CV protection in diabetes?
Curr Opin Pharmacol. 2020 Oct;54:202-208. doi: 10.1016/j.coph.2020.10.018. Epub 2020 Nov 30.
2
Renal protection with glucagon-like peptide-1 receptor agonists.
Curr Opin Pharmacol. 2020 Oct;54:91-101. doi: 10.1016/j.coph.2020.08.018. Epub 2020 Oct 5.
3
Disruption of energy utilization in diabetic cardiomyopathy; a mini review.
Curr Opin Pharmacol. 2020 Oct;54:82-90. doi: 10.1016/j.coph.2020.08.015. Epub 2020 Sep 25.
4
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications.
Curr Opin Pharmacol. 2021 Apr;57:1-12. doi: 10.1016/j.coph.2020.08.005. Epub 2020 Sep 13.
5
Heart failure and diabetes: role of ATM.
Curr Opin Pharmacol. 2020 Oct;54:27-35. doi: 10.1016/j.coph.2020.06.007. Epub 2020 Aug 1.
6
Diabetes, and its treatment, as an effector of autonomic nervous system circuits and its functions.
Curr Opin Pharmacol. 2020 Oct;54:18-26. doi: 10.1016/j.coph.2020.06.006. Epub 2020 Jul 25.
8
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
Nat Rev Cardiol. 2020 Sep;17(9):585-607. doi: 10.1038/s41569-020-0339-2. Epub 2020 Feb 20.
9
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications.
Circ Res. 2016 May 27;118(11):1723-35. doi: 10.1161/CIRCRESAHA.115.306825.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验